Net Loss of Parmax Pharma reported to Rs 2.08 crore in the quarter ended September 2025 as against net loss of Rs 0.22 crore during the previous quarter ended September 2024. Sales declined 72.74% to Rs 2.53 crore in the quarter ended September 2025 as against Rs 9.28 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 2.53 | 9.28 | -73 |
| OPM % | -62.85 | 2.05 | - |
| PBDT | -1.82 | 0.18 | PL |
| PBT | -2.08 | -0.22 | -845 |
| NP | -2.08 | -0.22 | -845 |
Powered by Capital Market - Live News